HR+/HER2- Advanced and/or Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HR+/HER2- Advanced and/or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer (NCT05044988) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-09-30 |
Track HR+/HER2- Advanced and/or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.